WallStreetZenWallStreetZen

NASDAQ: YS
Ys Biopharma Co Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

YS past revenue growth

How has YS's revenue growth performed historically?
Company
-11.42%
Industry
151.46%
Market
17.61%
YS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
YS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

YS earnings and revenue history

Current Revenue
$560.8M
Current Earnings
-$512.8M
Current Profit Margin
-91.4%

YS Return on Equity

Insufficient data to display
YS's Return on Equity (-186.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when YS announces earnings.

YS Return on Assets

Current Company
-32.5%
Current Industry
2.2%
YS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

YS Return on Capital Employed

Current Company
-43.9%
Current Industry
17.7%

YS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
YS$560.76M-$372.43M-$512.78M-11.42%N/A
ENTX$0.00-$8.80M-$8.89M-100.00%N/A
SPRO$103.78M$25.77M$22.81M+92.11%N/A
ATHA$0.00-$116.49M-$117.67MN/AN/A
QTTB$1.16M-$110.32M-$112.96M-26.32%N/A
View Top Biotech Stocks

Ys Biopharma Co Earnings & Revenue FAQ

What were YS's earnings last quarter?

Ys Biopharma Co (NASDAQ: YS) reported Q3 2023 earnings per share (EPS) of -$1.13, up 907.14% year over year. Total Ys Biopharma Co earnings for the quarter were -$104.98 million. In the same quarter last year, Ys Biopharma Co's earnings per share (EPS) was $0.14.

If you're new to stock investing, here's how to buy Ys Biopharma Co stock.

What was YS's earnings growth in the past year?

As of Q2 2024, Ys Biopharma Co's earnings has grown year over year. Ys Biopharma Co's earnings in the past year totalled -$512.78 million.

What was YS's revenue last quarter?

Ys Biopharma Co (NASDAQ: YS) reported Q3 2023 revenue of $96.82 million up 50.11% year over year. In the same quarter last year, Ys Biopharma Co's revenue was $194.06 million.

What was YS's revenue growth in the past year?

As of Q2 2024, Ys Biopharma Co's revenue has grown -11.42% year over year. This is 162.88 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Ys Biopharma Co's revenue in the past year totalled $560.76 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.